BeOne Medicines (BEIGF) Preferred Stock Liabilities (2015)

BeOne Medicines (BEIGF) has reported Preferred Stock Liabilities for 1 consecutive years, with $176.1 million the latest figure, recorded in Q4 2015.

• On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $176.1 million in Q4 2015; TTM through Dec 2015 was $176.1 million, a N/A change from a year earlier, with the FY2015 full-year figure at $176.1 million, changed N/A from the prior year.
• Preferred Stock Liabilities was $176.1 million for Q4 2015 at BeOne Medicines.
• Over five years, Preferred Stock Liabilities peaked at $176.1 million in Q4 2015 and troughed at $176.1 million in Q4 2015.